Feasibility and Safety of Using an Esophageal Protective System to Eliminate Esophageal Thermal Injury: Implications on Atrial-Esophageal Fistula Following AF Ablation |
| |
Authors: | MAURICIO S. ARRUDA,M.D.,LUCIANA ARMAGANIJAN,M.D.,&dagger ,LUIGI DI BIASE,M.D.,&Dagger ,¶ ,RASSOLL RASHIDI,B.M.E.,§ , ANDREA NATALE,M.D.,&Dagger |
| |
Affiliation: | From the Case Western Reserve University School of Medicine, Cleveland, Ohio, USA;;Hamilton Health Sciences, Hamilton, Ontario, Canada;;Texas Cardiac Arrhythmias Institute, Austin, Texas, USA;;Department of Cardiology, University of Foggia, Foggia, Italy;;and RossHart Technologies Inc., Cleveland, Ohio, USA |
| |
Abstract: | Background: Ablation for atrial fibrillation (AF) requires energy delivery in close proximity to the esophagus (Eso) which has accounted for the LA-Eso fistula, a rare but life-threatening complication. Purpose: We evaluated an Eso cooling system to protect the Eso during RF ablation. Methods and Results: An in vitro heart-Eso preparation was initially used to test a temperature-controlled fluid-circulating system (EPSac [esophageal protective system]—RossHart Technologies Inc.) and an expandable compliant Eso sac during cardiac RF delivery (4 mm tip, perpendicular to the heart, 15 g pressure) at 25, 35, and 45 W, 100 ± 5 Ω for 30 seconds with the EPSac at 25, 15, 10, and 5°C. All cardiac lesions were transmural. Eso thermal injury could only be avoided with the EPSac at 10 and 5°C. The system was then tested in 6 closed chest dogs, each receiving 12 RFs (LA aiming at the Eso) for 30 seconds: without EPSac (control) at 35 W (1 dog); at 45 W with EPSac at 25°C (1 dog), 10°C (2 dogs), and 5°C (2 dogs). The EPSac volume was intentionally increased to displace the Eso toward the LA (2 dogs 5 and 10°C). Eso injured control and EPSac at 25°C; Eso spared EPSac at 5 and 10°C, without Eso displacement. Shallow external Eso injury noted when intentionally displacing the Eso toward the LA. Conclusions: The EPSac spares the Eso from collateral thermal injury. It requires circulating fluid at 5 or 10°C and a compliant sac to avoid displacement of the Eso. Its safety and efficacy remain to be demonstrated in patients undergoing AF ablation. |
| |
Keywords: | atrial fibrillation atrioesophageal fistula catheter ablation pulmonary vein isolation treatment of atrial fibrillation |
|
|